EGFR activation-induced decreases in claudin1 promote MUC5AC expression and exacerbate asthma in mice
暂无分享,去创建一个
Min Hong | Wei-Yuan Yuan | Kai-fan Bao | Xuerui Yu | Yuheng Zhang | Jie Zheng | Xiaoyu Wang | Zhirong Jia | Lianqu Li | Yong-qing Hua | Xiaotong Wang | Lu Yao | Siqi Wang | Pan Wei | Peng Wu
[1] A. Andiappan,et al. Role of IL-13Ra2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa , 2019, Airway cell biology and immunopathology.
[2] Y. Gon,et al. Role of airway epithelial barrier dysfunction in pathogenesis of asthma. , 2018, Allergology international : official journal of the Japanese Society of Allergology.
[3] Jiao Song,et al. The Chronic and Short-Term Effects of Gefinitib on Airway Remodeling and Inflammation in a Mouse Model of Asthma , 2016, Cellular Physiology and Biochemistry.
[4] H. Vliagoftis,et al. Airway Epithelium Interactions with Aeroallergens: Role of Secreted Cytokines and Chemokines in Innate Immunity , 2015, Front. Immunol..
[5] D. Schwartz,et al. The polymeric mucin Muc5ac is required for allergic airway hyperreactivity , 2015, Nature Communications.
[6] R. Crystal. Airway basal cells. The "smoking gun" of chronic obstructive pulmonary disease. , 2014, American journal of respiratory and critical care medicine.
[7] S. Georas,et al. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. , 2014, The Journal of allergy and clinical immunology.
[8] D. Sheppard,et al. The cell biology of asthma , 2014, The Journal of cell biology.
[9] P. Howarth,et al. TNF-α-mediated bronchial barrier disruption and regulation by src-family kinase activation. , 2013, The Journal of allergy and clinical immunology.
[10] A. Yu,et al. Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.
[11] S. Georas,et al. Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells , 2013, Tissue barriers.
[12] H. Tsutsumi,et al. Regulation of Tight Junctions in Upper Airway Epithelium , 2012, BioMed research international.
[13] M. Castro,et al. Immune responses to self-antigens in asthma patients: clinical and immunopathological implications. , 2012, Human immunology.
[14] Hideki Chiba,et al. Possible Involvement of Tight Junctions, Extracellular Matrix and Nuclear Receptors in Epithelial Differentiation , 2011, Journal of biomedicine & biotechnology.
[15] Y. Soini. Claudins in lung diseases , 2011, Respiratory research.
[16] Douglas C Johnson,et al. Airway mucus function and dysfunction. , 2011, The New England journal of medicine.
[17] J. Whitsett,et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[18] Y. Okayama,et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. , 2009, The Journal of allergy and clinical immunology.
[19] S. Muller,et al. Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma. , 2009, American journal of respiratory and critical care medicine.
[20] J. Nadel,et al. Fibrinogen binding to ICAM-1 promotes EGFR-dependent mucin production in human airway epithelial cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[21] Wai-ming Lee,et al. Rhinovirus-induced Major Airway Mucin Production Involves a Novel Tlr3-egfr–dependent Pathway , 2009 .
[22] M. Balda,et al. Tight junctions and the regulation of gene expression. , 2009, Biochimica et biophysica acta.
[23] Kyubo Kim,et al. Mucus hypersecretion in asthma: causes and effects , 2009, Current opinion in pulmonary medicine.
[24] H. Hoogsteden,et al. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. , 2008, Canadian journal of physiology and pharmacology.
[25] S. Holgate. Epithelium dysfunction in asthma. , 2007, The Journal of allergy and clinical immunology.
[26] Eun Joo Lee,et al. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation , 2007, Experimental & Molecular Medicine.
[27] L. Cohn. Mucus in chronic airway diseases: sorting out the sticky details. , 2006, The Journal of clinical investigation.
[28] B. Stripp,et al. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. , 2004, American journal of respiratory cell and molecular biology.
[29] E. Gelfand,et al. Histopathology of severe childhood asthma: a case series. , 2003, Chest.
[30] J. Fahy. Goblet cell and mucin gene abnormalities in asthma. , 2002, Chest.
[31] D. Thornton,et al. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. , 2002, The Biochemical journal.
[32] P. Howarth,et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. , 2001, American journal of respiratory cell and molecular biology.
[33] P. Howarth,et al. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. , 2002, The Journal of allergy and clinical immunology.
[34] P. Burgel,et al. The role of epidermal growth factor in mucus production. , 2001, Current opinion in pharmacology.
[35] J. Nadel. Role of epidermal growth factor receptor activation in regulating mucin synthesis , 2001, Respiratory research.
[36] J. Nadel,et al. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. , 2001, American journal of respiratory and critical care medicine.
[37] R. Wu,et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. , 2001, American journal of respiratory and critical care medicine.
[38] K. Fujimoto,et al. A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts , 1998, The Journal of cell biology.
[39] Y. Nasuhara,et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. , 1998, American journal of respiratory and critical care medicine.
[40] K. Shirato,et al. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. , 1996, The European respiratory journal.
[41] D. Rogers,et al. Airway goblet cells: responsive and adaptable front-line defenders. , 1994, The European respiratory journal.